Skoči na glavni sadržaj

Izvorni znanstveni članak

https://doi.org/10.3325/cmj.2016.57.442

Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe

Jeffrey V Lazarus ; CHIP, Department of Infectious Diseases, Rigshospitalet, Universityof Copenhagen, Copenhagen, Denmark
Ida Sperle ; CHIP, Department of Infectious Diseases, Rigshospitalet, Universityof Copenhagen, Copenhagen, Denmark
Alexander Spina ; Centre for Infectious Disease Epidemiology, Austrian Agencyfor Health and Food Safety (AGES),Vienna, Austria
Jürgen K Rockstroh ; Department of Medicine I, University Hospital Bonn, Bonn, Germany


Puni tekst: engleski pdf 558 Kb

str. 442-456

preuzimanja: 485

citiraj


Sažetak

Aim To investigate whether or not key populations affected
by hepatitis B and hepatitis C are being tested sufficiently
for these diseases throughout the European region.
Methods We searched MEDLINE and EMBASE for studies
on HBV and HCV testing in the 53 Member States of
the World Health Organization European Region following
PRISMA criteria.
Results 136 English-language studies from 24 countries
published between January 2007 and June 2013 were
found. Most studies took place in 6 countries: France, Germany,
Italy, the Netherlands, Turkey, and the United Kingdom.
37 studies (27%) addressed HBV, 46 (34%) HCV, and 53
(39%) both diseases. The largest categories of study populations
were people who use drugs (18%) and health care
patient populations (17%). Far fewer studies focused on migrants,
prison inmates, or men who have sex with men.
Conclusions The overall evidence base on HBV and HCV
testing has considerable gaps in terms of the countries
and populations represented and validity of testing uptake
data. More research is needed throughout Europe to guide
efforts to provide testing to certain key populations.

Ključne riječi

Hrčak ID:

170459

URI

https://hrcak.srce.hr/170459

Datum izdavanja:

15.10.2016.

Posjeta: 905 *